Delivered psychosocial intervention in COPD: a feasibility study
Tanggal: 01/02/18
Topik: Medis


Psychosocial interventions have been shown to improve psychological and physical outcomes in COPD. However, due to the poor physical functioning of this population, uptake and attendance rates are low for face-to-face delivered interventions.

Anders Løkke1, Ingeborg Farver-Vestergaard2, Elisabeth Bendstrup1, Maja O'Connor2 and Robert Zachariae2
1Aarhus University Hospital, Aarhus, Denmark, 2Aarhus University, Aarhus, Denmark

 

Background: Psychosocial interventions have been shown to improve psychological and physical outcomes in COPD. However, due to the poor physical functioning of this population, uptake and attendance rates are low for face-to-face delivered interventions.

Aim: Our aim was therefore to evaluate the feasibility of home-based, technology-delivered mindfulness-based cognitive therapy (MBCT) for COPD patients.

Methods: Eight patients with severe to very severe COPD (mean age=72.6 yrs (SD=9.9); 50% women) received a standardized 8-week MBCT program delivered real-time via home-based tele-monitors in 2 groups of four. The participants completed measures of psychological distress (The Hospital Anxiety and Depression Scale) and physical health status (The COPD Assessment Test) pre and post intervention.


Read More : Inhaled corticosteroid related pneumonia in real world among the patients with asthma and COPD


Results:
The average attendance rate was 7.5 (SD=0.8) out of 8 sessions and no participants dropped out. A medium (Cohen’s d = 0.504) reduction in HADS scores was observed from pre (Mean=15.88, SD=9.26) to post-intervention (Mean=14.48, SD=5.73). Likewise, a medium-large reduction (d=0.743) in CAT scores was seen from pre (M=20.38, SD=2.83) to post-intervention (Mean=18.88, SD=4.64). For both outcomes, the differences failed to reach statistical significance (p=0.399 and 0.156).

Conclusion: Technology-delivered MBCT could be a feasible intervention in COPD. Large-scale, randomised controlled trials are needed to explore its efficacy on psychological and physical outcomes.








Artikel ini diambil dari Perhimpunan Dokter Paru Indonesia
http://www.klikpdpi.com

URL (alamat situs web) artikel ini adalah:
http://www.klikpdpi.com/modules.php?name=News&file=article&sid=8301